Latest Regulatory News

G8 Education’s 2025 full year results reveal significant occupancy challenges amid affordability pressures and sector confidence issues, alongside a $350 million goodwill impairment. Despite these hurdles, the company maintains a strong focus on child safety, operational discipline, and cautious capital management.

Norfolk Metals has confirmed the US$250,000 option payment for the Carmen Copper Project in Chile and completed the environmental impact report, setting the stage for further exploration and eventual ownership consolidation.

Critical Resources Limited has identified three priority targets at its Lammerlaw Gold Project in New Zealand, validating the area’s gold potential ahead of permit approval and outlining a cost-effective exploration strategy.

New Frontier Minerals has identified significant exploration targets across 14 prospects in its NWQ Copper Project, with plans to advance the Big One Deposit towards production.

Cash Converters International Limited reported an 8% rise in half-year revenue to $206.7 million, driven by franchise acquisitions and a shift in lending strategy. Despite a 17% dip in net profit due to one-off costs, the company declared a fully franked interim dividend and reinstated its Dividend Reinvestment Plan.

Chorus Limited has reported a strong half-year performance driven by fibre broadband growth, operational efficiencies, and a return to profitability, while launching initiatives to boost digital inclusion.

Fisher & Paykel Healthcare has raised its full-year revenue and profit forecasts for FY26, buoyed by strong hospital product growth and favourable exchange rates, while navigating the complexities of a recent US Supreme Court tariff ruling.

Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.

Big gains hit wealth platforms while Zip swung the other way as early optimism didn’t stick. Dividends and buy-backs kept coming, but investors still punished stocks where the next step looks unclear.

Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.

Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.

FortifAI’s funding and big claims around faster AI data processing drove the week’s loudest move, while two small caps jumped on price queries. Elsewhere, results season rewarded clear recurring revenue growth, but punished gaps where early buying didn’t stick.